ArnabBasuMDMPH

PubMed

• 35 citations
  Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
  Vadim S Koshkin, Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman
  Cancer. 2022-03-15
• 52 citations
  Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients
  Monica Khunger, Pradnya D. Patil, Arjun Khunger, Manshi Li, Bo Hu
  Plos One. 2018-10-25
• 5 citations
  Emerging perioperative therapeutic approaches in muscle invasive bladder cancer.
  Goutham Patil, Arnab Basu
  Therapeutic Advances in Urology. 2022-10-28

Journal Articles

• Association of PD-L1, PD-L2, and Immune Response Markers in Matched Renal Clear Cell Carcinoma Primary and Metastatic Tissue Specimens  
  Arnab Basu, MD, American Journal of Clinical Pathology
• “Palliative care in low and medium resource countries  
  Basu A, Mittag-Leffler N, Miller K, Cancer Journal, 9/2013

Books/Book Chapters

• Global Perspectives on Cancer: Incidence, Care, and Experience 
  Chapter: Palliative Care for Oncology Patients in the 21st Century: A Global Perspective 
  Kenneth MillerEditors: Kenneth Miller.ABC-CLIO Press 2015

Abstracts/Posters

• “Platelet Activation Markers and Aggregation in Patients with Advanced Adenocarcinoma undergoing Chemotherapy: Correlation with Khorana Scores
  Basu A., Gosain R., Tantry U, Miller K, Gurbel. P, European Cancer Congress, Vienna, Austria, 9/2015
• Oncologists' perception of residual cancer recurrence risk and recommended follow-up care
  Basu A., Gosain R., Opneja A., Miller K, J Clin Oncol 2015 (suppl; e22003), ASCO - 2015, 6/2015
• A Correlative Study of Platelet Aggregation with Chemotherapy Associated Thrombosis
  Basu A., Gosain R., Tantry U, Miller K, ACP - Maryland State Meeting, Baltimore, Maryland, 5/14/2015
• Platelet reactivity in advanced adenocarcinoma patients and healthy controls
  Basu A., Gosain R., Tantry U , Miller K, J Clin Oncol 2015 (suppl; e20619), ASCO - 2015, 5/5/2015
• “ A case report of unicentric plasma cell variant castleman disease in the absence of HIV and HHV8
  Basu A, Banavali A, Miller, American Thoracic Society Meeting, Denver, Colorado, 5/2015
• a case of recalcitrant sarcoma – is personalized targeted therapy the answer?
  Basu A, Park H, Subbiah V, American Medical Association - Research Symposium, Dallas, Texas, 11/2014
• Levamisole induced skin necrosis syndrome: A case report
  Basu A, Singh A, Gradon J:, Maryland ACP Meeting, Baltimore, Maryland, 5/2014
• “A decade of incubation : Malignant transformation of an iliac crest amyloidoma”
  Singh A, Basu A, Miller, National ACP Conference, Orlando Florida, 4/2014
• Total Lymphocyte count and lymphocyte morphology as a monitoring tool for HIV infected patients in resource limited settings
  Basu A, Gupta S, Guha S, International Conference on Opportunistic Pathogens in AIDS, All India Institute of Medical Sciences , Delhi, India, 2008
• Join now to see all